Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Ipamorelin Dosing Protocol: 5 mg Vial — Selective GHRP Daily

Ipamorelin 5 mg vial: 2 mg/mL, 200–300 μg (10–15 units) nightly. No cortisol elevation. CJC-1295 combination guide. Reviewed Feb 2026. Reviewed Feb 2026.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Ipamorelin Dosing Protocol: 5 mg Vial — Daily Dosing Schedule & Supplies

Week-by-week ipamorelin dosing guide using the 5 mg vial — the cleanest GHRP for precise, cortisol-free growth hormone stimulation.

Quickstart highlights

Ipamorelin (Ala-His-D-2-Nal-D-Phe-Lys-NH2) is a pentapeptide ghrelin receptor agonist (GHSR-1a) that selectively stimulates GH release without activating ACTH/cortisol or prolactin axes — distinguishing it from GHRP-2 and GHRP-6.

Concentration: 2 mg/mL (5 mg vial + 2.5 mL bacteriostatic water).

At 2 mg/mL: 200 μg = 10 units, 300 μg = 15 units.

Ipamorelin does not elevate cortisol or prolactin — the most selective GHRP available.

Combine with CJC-1295 or sermorelin for 2–4x greater GH secretion versus ipamorelin alone.

Inject in fasted state (2+ hours post-meal); food-driven insulin blunts GH response.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

1-4

200

10

Once daily (before bed)

200 μg — 10 units; single nightly injection; one vial provides 25 doses

5-12

300

15

Once or twice daily

300 μg — 15 units; add morning injection for enhanced GH pulsatility if desired

13+

2–3x daily

300 μg 2–3x daily for maximum GH secretion; space 4+ hours between doses

Your free Ipamorelin tracker

Dose reminders

Injection logging

Cycle progress

Reconstitution steps

Draw 2.5 mL bacteriostatic water; inject slowly down the vial wall.

Swirl gently until powder fully dissolves; do not shake.

Final concentration: 2 mg/mL (2,000 μg/mL). At this concentration: 200 μg = 10 units, 300 μg = 15 units.

Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

4-week plan

1 vial

28 syringes

3 mL bac water

28 alcohol swabs

8-week plan

2 vials

56 syringes

5 mL bac water

56 alcohol swabs

12-week plan

84 syringes

84 alcohol swabs

Protocol overview & cycle notes

Stimulate clean, pulsatile GH release through ghrelin receptor agonism with ipamorelin — the most selective GHRP available, producing meaningful GH secretion without cortisol, prolactin, or significant cortisol elevation.

Cycle length: 12 weeks on.

Off-cycle: 4 weeks off after every 12-week cycle.

Storage & handling

Injection & tracking tips

Inject subcutaneously in fasted state or 2 hours post-meal; insulin elevation suppresses GH response to ipamorelin.

Ipamorelin does not elevate cortisol or prolactin — a key advantage over GHRP-2 and GHRP-6 at equivalent doses.

When combining with CJC-1295 or sermorelin, inject both peptides simultaneously or within 5 minutes — GHRH + GHRP synergy is immediate.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

Measure IGF-1 at baseline and 6 weeks; ipamorelin typically raises IGF-1 by 30–50 ng/mL per 12-week cycle.

Track sleep quality nightly (wearable deep sleep data or subjective 0–10 scale).

Monitor fasting glucose monthly — GH elevation can transiently increase glucose at higher doses.

How this works & references

Sources

Ipamorelin, the first selective growth hormone secretagogue. Raun K et al. — Eur J Endocrinol — 1998

Source: Bowers CY — Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab. 2001

Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Gobburu JV et al. — Pharm Res — 1999

Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Beck DE et al. — Int J Colorectal Dis — 2014

Frequently asked questions

Related protocols

KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide

KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.

GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide

GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Connected topics

Follow this recovery question